What’s Propelling Utah Medical Products, Inc. (UTMD) to Reach 52-Week High?

April 24, 2018 - By Winifred Garcia

Investors sentiment increased to 1.75 in 2017 Q4. Its up 0.18, from 1.57 in 2017Q3. It is positive, as 5 investors sold Utah Medical Products, Inc. shares while 19 reduced holdings. 14 funds opened positions while 28 raised stakes. 2.40 million shares or 0.23% less from 2.41 million shares in 2017Q3 were reported.
Wells Fargo & Mn invested in 28,464 shares or 0% of the stock. Northern Corp owns 0% invested in Utah Medical Products, Inc. (NASDAQ:UTMD) for 52,860 shares. Cambridge Invest reported 3,546 shares stake. Acadian Asset Mngmt Ltd accumulated 1,598 shares. Seizert Prns Ltd Liability owns 0.02% invested in Utah Medical Products, Inc. (NASDAQ:UTMD) for 5,704 shares. Bridgeway Mgmt Incorporated holds 25,550 shares or 0.02% of its portfolio. 3,745 were accumulated by First Quadrant Limited Partnership Ca. Geode Cap Mngmt Limited Company holds 49,184 shares. Price T Rowe Associate Md has invested 0% in Utah Medical Products, Inc. (NASDAQ:UTMD). Stratos Wealth accumulated 465 shares or 0% of the stock. Metropolitan Life Insur accumulated 1,319 shares. Massachusetts-based Martingale Asset Mgmt L P has invested 0.02% in Utah Medical Products, Inc. (NASDAQ:UTMD). Barclays Public Ltd Co reported 1,142 shares or 0% of all its holdings. Janney Montgomery Scott Ltd accumulated 0% or 5,678 shares. Rhumbline Advisers has 3,209 shares for 0% of their portfolio.

Since February 2, 2018, it had 0 insider buys, and 8 sales for $1.56 million activity. HOYER ERNST G sold $464,447 worth of Utah Medical Products, Inc. (NASDAQ:UTMD) on Thursday, February 15. PAYNE BARBARA A also sold $90,700 worth of Utah Medical Products, Inc. (NASDAQ:UTMD) on Friday, February 16.

The stock of Utah Medical Products, Inc. (NASDAQ:UTMD) hit a new 52-week high and has $115.67 target or 7.00 % above today’s $108.10 share price. The 9 months bullish chart indicates low risk for the $402.76 million company. The 1-year high was reported on Apr, 24 by Barchart.com. If the $115.67 price target is reached, the company will be worth $28.19M more.
The 52-week high event is an important milestone for every stock because it shows very positive momentum and is time when buyers come in. During such notable technical setup, fundamental investors usually stay away and are careful shorting or selling the stock.

The stock decreased 0.51% or $0.55 during the last trading session, reaching $108.1. About 6,040 shares traded. Utah Medical Products, Inc. (NASDAQ:UTMD) has risen 57.70% since April 24, 2017 and is uptrending. It has outperformed by 46.15% the S&P500.

Utah Medical Products, Inc. develops, makes, and distributes medical devices for the healthcare industry worldwide. The company has market cap of $402.76 million. It provides fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD, an infant respiratory hood; and DELTRAN PLUS, a blood pressure monitoring system. It has a 47.5 P/E ratio. The firm also offers umbilical vessel catheters; DIALY-NATE, a disposable peritoneal dialysis set; PALA-NATE, a silicone oral protection device; URI-CATH, a urinary drainage system; and MYELO-NATE, a lumbar sampling kit.

Utah Medical Products, Inc. (NASDAQ:UTMD) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: